Have a personal or library account? Click to login
Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement Cover

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Acta Marisiensis - Seria Medica
Volume 69 (2023): Issue 1 (March 2023)
By:
Open Access
|Mar 2023

Metrics

DOI: https://doi.org/10.2478/amma-2023-0009 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 11 - 16
Submitted on: Oct 20, 2022
Accepted on: Feb 14, 2023
Published on: Mar 29, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
congenital heart disease,
tetralogy of Fallot,
pentalogy of Fallot,
blood biomarkers,
pulmonary valve replacement
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2023 Milla Marika Kainlauri, Irina-Bianca Kosovski, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 69 (2023): Issue 1 (March 2023)Next article